Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF, 3060K) PDF+supp data (5042K) PPT slides of all figures Supplemental Material Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via CrossRef Google Scholar Articles by Fogelstrand, P. Articles by Ginsberg, M. H. PubMed PubMed Citation Articles by Fogelstrand, P. Articles by Ginsberg, M. H. Social Bookmarking                            What's this?

¹ Department of Medicine, University of California, San Diego, La Jolla, CA 92093
² Institut National de la Santé et de la Recherche Médicale Avenir Team, U634, Nice Sophia Antipolis University, 06107 Nice, Cedex 2, France

CORRESPONDENCE Mark H. Ginsberg: mhginsberg{at}ucsd.edu

Activation of vascular smooth muscle cells (VSMCs) to migrate and proliferate is essential for the formation of intimal hyperplasia. Hence, selectively targeting activated VSMCs is a potential strategy against vaso-occlusive disorders such as in-stent restenosis, vein-graft stenosis, and transplant vasculopathy. We show that CD98 heavy chain (CD98hc) is markedly up-regulated in neointimal and cultured VSMCs, and that activated but not quiescent VSMCs require CD98hc for survival. CD98hc mediates integrin signaling and localizes amino acid transporters to the plasma membrane. SMC-specific deletion of CD98hc did not affect normal vessel morphology, indicating that CD98hc was not required for the maintenance of resident quiescent VSMCs; however, CD98hc deletion reduced intimal hyperplasia after arterial injury. Ex vivo and in vitro, loss of CD98hc suppressed proliferation and induced apoptosis in VSMCs. Furthermore, reconstitution with CD98hc mutants showed that CD98hc interaction with integrins was necessary for the survival of VSMCs. These studies establish the importance of CD98hc in VSMC proliferation and survival. Furthermore, loss of CD98hc was selectively deleterious to activated VSMCs while sparing resident quiescent VSMCs, suggesting that activated VSMCs are physiologically dependent on CD98hc, and hence, CD98hc is a potential therapeutic target in vaso-occlusive disorders.

Abbreviations used: Adeno-Cre, adenovirus encoding Cre recombinase; Adeno-LacZ, adenovirus encoding β-galactosidase; CA, carotid artery; CD98hc, CD98 heavy chain; GMF, geometric mean fluorescence; PDGF, platelet-derived growth factor; PI, propidium iodide; TUNEL, Tdt-mediated dUTP-biotin nick-end labeling; VSMC, vascular smooth muscle cell.

© 2009 Fogelstrand et al.
This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jem.org/misc/terms.shtml). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS